🌍·2d agoResearch
A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- July 17, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Crossref/1d ago
Multifocal Vasculitic Acute Ischemic Stroke Secondary to Tubercular Meningitis with Caseating Parietal Tuberculoma and Cavitary Pulmonary Tuberculosis Co-morbid with Alcohol Dependence: A Rare Clinical Intersection
Crossref/1d ago
Investigating Intracerebral Hemorrhage Evacuation Procedure Volumes Before and After the Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) Trial
Crossref/1d ago
Etiology and Clinical Characteristics of Conductive Hearing Loss at a Tertiary Hospital in Sudan
Crossref/1d ago